Now showing items 4399-4418 of 10378

    • Hiv Type 1 Subtypes In Circulation In Northern Kenya. 

      Khamadi, S A; Ochieng, W; Lihana, R W; Kinyua, J; Muriuki, J; Mwangi, J; Lwembe, R; Kiptoo, M; Osman, S,; Lagat, N; Pelle, R; Muigai, A; Carter, J Y; Oishi, I; Ichimura, H; Mwaniki, D L; Okoth, F. A; Mpoke, S; Songok, E M (University of NairobiSchool of Public Health Centre for HIV Prevention and Research, 2005)
      Kenya Medical Research Institute, Nairobi, Kenya. skhamadi@nairobi.mimcom.net The genetic subtypes of HIV-1 circulating in northern Kenya have not been characterized. Here we report the partial sequencing and analysis of ...
    • HIV type 1 transmission networks among men having sex with men and heterosexuals in Kenya 

      Bezemer, Daniela; Faria, Nuno Rodrigues; Hassan, Amin; Hamers, Raph L; Mutua, Gaudensia; Anzala, Omu; Mandaliya, Kishor; Cane, Patricia; Berkley, James A; Rinke, de Wit Tobias F; Wallis, Carole; Graham, Susan M; Price, Matthew; Coutinho, Roel A; Sanders, Eduard J (University of Nairobi, 2014)
      We performed a molecular phylogenetic study on HIV-1 polymerase sequences of men who have sex with men (MSM) and heterosexual patient samples in Kenya to characterize any observed HIV-1 transmission networks. HIV-1 polymerase ...
    • Hiv Vaccine Efficacy Trials: A Brief History, And Options For Going Forward. 

      McKinnon, LR; Card, CM; CIHR International Infectious Diseases and Global Health Training Program (IID&GHTP). (University of NairobiDepartment of Medical Microbiology, 2010-10)
      HIV vaccine research has recently produced a number of efficacy results, in addition to some promising preclinical developments. Some of these have been surprising, leading to parallel calls for a better understanding of ...
    • HIV viral set point and host immune control in individuals with HIV-specific CD8R T-cell responses prior to HIV acquisition 

      Kaul, Rupert; MacDonald, Kelly S.; Nagelkerke, Nico J.; Kimani, Joshua; Fowke, Keith; Ball, T. Blake; Luo, Ma; Kariri, Anthony; Jaoko Walter G.; Moses, Stephen; Rowland-Jones, Sarah; Plummer, Francis A (2010)
      OBJECTIVE: Vaccine-induced CD8(+) T-cell responses in primates have been associated with a reduced simian immunodeficiency virus plasma viral load and enhanced T-cell responses, but cellular vaccines have shown limited ...
    • HIV with non-communicable diseases in primary care in Kibera, Nairobi, Kenya: characteristics and outcomes 2010–2013 

      Edwards, Jeffrey K; Bygrave, Helen; Van den Bergh, Rafael; Kizito, Walter; Cheti, Erastus; Kosgei, Rose J; Sobry, Agnès; Vandenbulcke, Alexandra; Vakil, Shobha N; Reid, Tony (University of Nairobi, 2015)
      BACKGROUND: Antiretroviral therapy (ART) has increased the life expectancy of people living with HIV (PLHIV); HIV is now considered a chronic disease. Non-communicable diseases (NCDs) and HIV care were integrated into ...
    • HIV, violence and women: Unmet mental health care needs 

      Zunner, Brian; Dworkin, Shari L; Neylan, Thomas C; Bukusi, Elizabeth A; Oyaro, Patrick; Cohen, Craig R; Abwok, Matilda; Meffer, Susan M (University of Nairobi, 2014-12)
      Background HIV-infected (HIV+) women have high rates of Gender Based Violence (GBV). Studies of GBV find that approximately 50–90% of survivors develop mood and anxiety disorders. Given that women in sub-Saharan African ...
    • HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behaviour among Kenyan female sex workers. 

      McClelland, RS; Hassan, WM; Lavreys, L; Richardson, BA; Mandaliya, K; Ndinya-Achola, JO; Jaoko Walter G. (2006)
      BACKGROUND: Changes in sexual risk behaviour may occur following HIV-1 infection. OBJECTIVE: To test the hypothesis that HIV-1 seroconversion and disease progression are associated with changes in risk behaviours, ...
    • HIV-1 and immunological changes during pregnancy: a comparison between HIV-1-seropositive and HIV-1-seronegative women in Nairobi, Kenya. 

      Piot, P; Ndinya-Achola, JO; Chomba, E N; Temmerman, M; Nagelkerke, N; Bwayo, JJ (University of NairobiDepartment of Obstetrics and Gynaecology, 1995-09-09)
      OBJECTIVE: To assess changes in the proportion of CD4 and CD8 T-lymphocyte profiles during pregnancy, at delivery and postpartum, and to determine whether HIV-1 infection affects the normal profile. DESIGN AND METHODS: A ...
    • HIV-1 and reproductive health in Africa 

      Temmerman, M; Chomba, E N; Piot, P (University of NairobiDepartment of Medical Microbiology, 1994-02)
      In many African countries where HIV infection is mainly heterosexually transmitted a substantial proportion of women of childbearing age are now infected with the virus. This paper will review the consequences of HIV-1 ...
    • HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort 

      McKinnon, Lyle R; Nagelkerke, Nico J; Kaul, Rupert; Shaw, Souradet Y; Capina, Rupert; Luo, Ma; Kariri, Anthony; Apidi, Winnie; Kimani, Makobu; Wachihi, Charles; Jaoko, Walter; Anzala, A Omu; Kimani, Joshua; Ball, T Blake; Plummer, Francis A (University of Nairobi, 2012)
      HIV-1 is grouped phylogenetically into clades, which may impact rates of HIV-1 disease progression. Clade D infection in particular has been shown to be more pathogenic. Here we confirm in a Nairobi-based prospective female ...
    • HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort 

      McKinnon, Lyle R.; Nagelkerke, Nico J.; Kaul, Rupert; Shaw, Souradet Y.; Capina, Rupert; Luo, Ma; Kariri, Anthony; Apidi, Winnie; Kimani, Makobu; Wachihi, Charles; Jaoko Walter G.; Anzala Aggrey O.; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A. (2012)
      HIV-1 is grouped phylogenetically into clades, which may impact rates of HIV-1 disease progression. Clade D infection in particular has been shown to be more pathogenic. Here we confirm in a Nairobi-based prospective ...
    • HIV-1 disease progression in breast-feeding and formula-feeding mothers: 

      Otieno, Phelgona A; Brown, Elizabeth R; Mbori-Ngacha, DA; Nduati, RW; Farquhar, Carey; Obimbo, Elizabeth M; Bosire, Rose K; Emery, Sandy; Overbaugh, Julie; Richardson, Barbra A; John-Stewart, Grace C (Department of Pediatrics, University of Nairobi, Nairobi, Kenya, 2007)
      Background. There is conflicting evidence regarding the effects of breast‐feeding on maternal mortality from human immunodeficiency virus type 1 (HIV‐1) infection, and little is known about the effects of breast‐feeding ...
    • HIV-1 Drug Resistance Mutations Among Infants Born to HIV-Positive Mothers in Busia, Kenya 

      Lel, Rency; Ngaira, Jane; Lihana, Raphael; Khamadi, Samoel. (University of Nairobi, 2014)
      To determine HIV-1 subtypes and transmitted HIV-1 drug-resistant mutations among HIV-1-positive children born to HIV-positive mothers in Busia County, blood samples were collected from 53 children aged between 6 weeks and ...
    • HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. 

      Kaul, R; Rutherford, J; Rowland-Jones, SL; Kimani, J; Onyango, JI; Fowke, K; MacDonald, K; Bwayo, JJ; McMichael, AJ; Plummer, FA (University of NairobiDepartment of Medical Microbiology, 2004-10-21)
      The prospective significance of HIV-specific cytotoxic T lymphocyte (CTL) responses in highly exposed, persistently seronegative populations is unknown. In 1996-1997 we screened for CTL responses against HIV clade B Env ...
    • HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response 

      Piantadosi, A; Chohan, B; Panteleeff, D; Baeten, JM; Mandaliya, K; Ndinya-Achola JO.; Overbaugh, J (Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USADepartment of Medical Microbiology, University of Nairobi, 2009)
      OBJECTIVE: To evaluate relationships between HIV-1 evolution, including immune evasion, and markers of disease progression during chronic infection. DESIGN: HIV-1 evolution and disease progression markers were evaluated ...
    • HIV-1 infection alters the retinol-binding protein:transthyretin ratio even in the absence of the acute phase response. 

      Baeten, JM; Wener, MH; Bankson, DD; Lavreys, L; Richardson, BA; Mandaliya, K; Bwayo, JJ; McClelland, R (University of Nairobi,College of Health Sciences,, 2005)
      he ratio of retinol-binding protein (RBP) to transthyretin (TTR) has been proposed as an indirect method with which to assess vitamin A status in the context of inflammation. Few studies have been conducted among adults, ...
    • HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype 

      Mabuka, J; Goo, L; Omenda, MM; Nduati, R; Overbaugh, J (University of NairobiSchool of Public Health, 2013-06-19)
      RATIONALE: To protect against HIV infection, passively transferred and/or vaccine-elicited neutralizing antibodies (NAbs) need to effectively target diverse subtypes that are transmitted globally. These variants are a ...
    • HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals. 

      Hirbod, T; Reichard, C; Hasselrot, K; Söderlund, J; Kimani, J; Bwayo, JJ; Plummer, F; Kaul, R; Broliden, K (University of Nairobi,College of Health Sciences,, 2008)
      AIM: Mucosal HIV-1 exposure stimulates a variety of mucosal immune responses, including IgA1-mediated virus neutralization, even in the absence of an established infection. We hypothesized that other immune molecules might ...
    • Hiv-1 neutralizing antibodies with limited hypermutation from an infant. 

      Simonich, Cassandra A.; Katherine, L. Williams; Verkerke, Hans P.; Williams, James A.; Nduati, Ruth; Lee, Kelly K.; Overbaugh, Julie (University of Nairobi, 2016)
      HIV-1 broadly neutralizing antibodies (bnAbs) develop in a subset of infected adults and exhibit high levels of somatic hypermutation (SHM) due to years of affinity maturation. There is no precedent for eliciting highly ...
    • HIV-1 neutralizing antibody breadth is affected by factors early in infection, but does not influence disease progression. Journal of Virology 83(10):10269-74 

      Piantadosi, A; Panteleeff, D; Blish, CA; Baeten, JM; Jaoko, W; McClelland, RS; Overbaugh, J (University of Nairobi, 2009)
      No abstract available